Document:

EX-10.9

 Exhibit 10.9 

Spouse Consent Letter 
 To: Genetron
(Tianjin) Co., Ltd. 
 Whereas: 
  

	1.	 I, Zhou Jing (ID card/passport number:
[            ]), am the spouse of the natural person Wang Sizhen (ID card number: [            ]). Wang Sizhen holds 14.695%
equity of Genetron Health (Beijing) Co., Ltd. (hereinafter referred to as “Target Equity Interest”) 

  

	2.	 With respect to the aforementioned Target Equity Interest held by Wang Sizhen, Wang Sizhen entered into the
Exclusive Option Agreement with other related parties on July 30, 2019, entered into the Equity Pledge Agreement with other related parties on July 30, 2019, and entered into the Shareholder Voting Rights Entrustment Agreement with other
related parties on July 30, 2019; and 

  

	3.	 Genetron Health (Beijing) Co., Ltd entered into the Exclusive Business Cooperation Agreement with Genetron
(Tianjin) Co., Ltd. on July 2, 2019. This Exclusive Business Cooperation Agreement together with the aforementioned Exclusive Option Agreement, Equity Pledge Agreement and Shareholder Voting Rights Entrustment Agreement constitute the
contractual control arrangement regarding Genetron Health (Beijing) Co., Ltd (hereinafter referred to as the “Contractual Control Arrangement”). 

I hereby confirm and irrevocably undertake as follows on July 30, 2019: 
  

	1.	 I confirm that I have noted and agree that my spouse Wang Sizhen entered into the Exclusive Call Agreement,
Equity Pledge Agreement and Shareholder Voting Rights Entrustment Agreement. The aforementioned Target Equity Interest of Genetron Health (Beijing) Co., Ltd held by Wang Sizhen is not our joint property. I have no rights and interests in such Target
Equity Interest, (including the rights gained from the Contractual Control Arrangement). I will never take any action to interfere with the Contractual Control Arrangement, including but not limited to claiming any right over the aforementioned
Target Equity Interest and the Contractual Control Arrangement. 

  

	2.	 I hereby undertake, I have not participated in and will not plan to actually participate in the operation and
management of Genetron Health (Beijing) Co., Ltd in the future, and I will not claim any right related to the equity interests and assets of Genetron Health (Beijing) Co., Ltd. 

  
 1 

	3.	 If, for any reason, I obtain all or part of the Target Equity Interest, I unconditionally agree to be a party
of the Contractual Control Arrangement and be bound by the Contractual Control Arrangement. In this respect, I undertake to take all necessary actions and to sign all necessary documents. 

This letter will take effect immediately upon its signature by me and will be continuously effective. 

  
 2 

 (This page is intentionally left blank and is the signing page of this Spouse Consent
Letter) 
  

			
	Undertaker’s Signature:	 	 /s/ Zhou Jing

	 	 	Date: July 30, 2019

  
 3EX-10.10

 Exhibit 10.10 

Spouse Consent Letter 
 To: Genetron
(Tianjin) Co., Ltd. 
 Whereas: 
  

	1.	 I, He Weiwu (ID card/passport number:
[            ]), am the spouse of the natural person Wang Xiaoge (ID card number: [            ]). Wang Xiaoge holds 6.544%
equity of Genetron Health (Beijing) Co., Ltd. (hereinafter referred to as “Target Equity Interest”) 

  

	2.	 With respect to the aforementioned Target Equity Interest held by Wang Xiaoge, Wang Xiaoge entered into the
Exclusive Option Agreement with other related parties on July 30, 2019, entered into the Equity Pledge Agreement with other related parties on July 30, 2019 and entered into the Shareholder Voting Rights Entrustment Agreement with other
related parties on July 30, 2019; and 

  

	3.	 Genetron Health (Beijing) Co., Ltd entered into the Exclusive Business Cooperation Agreement with Genetron
(Tianjin) Co., Ltd. on July 2, 2019. This Exclusive Business Cooperation Agreement together with the aforementioned Exclusive Option Agreement, Equity Pledge Agreement and Shareholder Voting Rights Entrustment Agreement constitute the
contractual control arrangement regarding Genetron Health (Beijing) Co., Ltd (hereinafter referred to as the “Contractual Control Arrangement”). 

Hereby, I confirm and irrevocably undertake as follows on July 30, 2019: 
  

	1.	 I confirm that I have noted and agree that my spouse Wang Xiaoge entered into the Exclusive Option Agreement,
Equity Pledge Agreement and Shareholder Voting Rights Entrustment Agreement. The aforementioned Target Equity Interest of Genetron Health (Beijing) Co., Ltd held by Wang Xiaoge is not our joint property. I have no rights and interests in such Target
Equity Interest, including the rights gained from the Contractual Control Arrangement. I will never take any action to interfere with the Contractual Control Arrangement, including but not limited to claiming any right over the aforementioned Target
Equity Interest and the Contractual Control Arrangement. 

  

	2.	 I hereby undertake, I have not participated in and will not plan to actually participate in the operation and
management of Genetron Health (Beijing) Co., Ltd in the future, and I will not claim any right related to the equity interests and assets of Genetron Health (Beijing) Co., Ltd. 

  
 1 

	3.	 If, for any reason, I obtain all or part of the aforementioned equity, I unconditionally agree to be a party of
the Contractual Control Arrangement and be bound by the Contractual Control Arrangement. In this respect, I undertake to take all necessary actions and to sign all necessary documents. 

This letter will take effect immediately upon its signature by me and will be continuously effective. 

  
 2 

 (This page is intentionally left blank and is the signing page of this Spouse Consent
Letter) 
  

			
	Undertaker’s Signature:	 	 /s/ He Weiwu

	 	 	Date: July 30, 2019

  
 3EX-10.11

 Exhibit 10.11 

Spouse Consent Letter 
 To: Genetron
(Tianjin) Co., Ltd. 
 Whereas: 
  

	1.	 I, Yan Shida (ID card number: [            ]), am
the spouse of the natural person Wei Shuyan (ID card number: [            ]). Wei Shuyan holds 11.050% equity of Genetron Health (Beijing) Co., Ltd.( hereinafter referred to as
“Target Equity Interest”); 

  

	2.	 With respect to the aforementioned Target Equity Interest held by Wei Shuyan, Wei Shuyan entered into the
Exclusive Option Agreement with other related parties on July 30, 2019, entered into the Equity Pledge Agreement with other related parties on July 30, 2019 and entered into the Shareholder Voting Rights Entrustment Agreement with other
related parties on July 30, 2019; and 

  

	3.	 Genetron Health (Beijing) Co., Ltd entered into the Exclusive Business Cooperation Agreement with Genetron
(Tianjin) Co., Ltd. on July 2, 2019. This Exclusive Business Cooperation Agreement together with the aforementioned Exclusive Option Agreement, Equity Pledge Agreement and Shareholder Voting Rights Entrustment Agreement constitute the
contractual control arrangement regarding Genetron Health (Beijing) Co., Ltd (hereinafter referred to as the “Contractual Control Arrangement”). 

Hereby, I confirm and irrevocably undertake as follows on July 30, 2019: 
  

	1.	 I confirm that I have noted and agree that my spouse Wei Shuyan entered into the Exclusive Option Agreement,
Equity Pledge Agreement and Shareholder Voting Rights Entrustment Agreement. The aforementioned Target Equity Interest of Genetron Health (Beijing) Co., Ltd held by Wei Shuyan is not our joint property. I have no rights and interests in such
Target Equity Interest, including the rights gained from the Contractual Control Arrangement. I will never take any action to interfere with the Contractual Control Arrangement, including but not limited to claiming any right over the aforementioned
Target Equity Interest and the Contractual Control Arrangement. 

  

	2.	 I hereby undertake, I have not actually participated in and will not plan to actually participate in the
operation and management of Genetron Health (Beijing) Co., Ltd in the future, and I will not claim any right related to the equity interests and assets of Genetron Health (Beijing) Co., Ltd. 

  
 1 

	3.	 If, for any reason, I obtain all or part of the aforementioned equity, I unconditionally agree to be a party of
the Contractual Control Arrangement and be bound by the Contractual Control Arrangement. In this respect, I undertake to take all necessary actions and to sign all necessary documents. 

This letter will take effect immediately upon its signature by me and will be continuously effective. 

  
 2 

 (This page is intentionally left blank and is the signing page of this Spouse Consent
Letter) 
  

			
	Undertaker’s Signature:	 	 /s/ Yan Shida

	 	 	Date: July 30, 2019

  
 3Exhibit 10.1

 

AGREEMENT AND RELEASE

 

The following   agreement and
release (the “Agreement”) is made and entered into on this  21st day of November, 2019 (the
 “Effective Date”) by and between David L. Fetherman (“Executive”) and Escalade,
Incorporated, an Indiana corporation (“Escalade”) regarding Executive’s retirement and resignation
from all positions held by Executive with Escalade and its various subsidiaries and affiliates. Escalade and Executive are
sometimes referred to collectively as the “parties” and individually as a “party,” and
the term “Company” shall mean Escalade and its various subsidiaries and affiliates collectively.

 

Recitals:

 

A. Executive
is the Chief Executive Officer and President of Escalade, a director of Escalade, and an officer and/or director of various subsidiaries
and affiliates of Escalade; and

 

B. Executive
has announced his intention to retire from all positions with the Company, and Executive and Escalade have reached agreement with
respect to all matters related to Executive’s retirement, Executive’s assistance in facilitating the transition to
Executive’s successor, and Executive’s resignation from all such positions, including the timing thereof; and

 

C. Executive’s
employment with the Company will terminate on (the “Employment End Date”) the earliest to occur of (i) the commencement
of employment by Escalade of a new Chief Executive Officer, (ii) a date that is mutually agreed upon by Executive and Escalade’s
Board of Directors, (iii) if requested by Escalade’s Board of Directors for any reason, the date established by the Board
of Directors on which Executive’s resignation is to be effective, or (iv) immediately upon a Change in Control of the Company,
and Executive then will cease to serve as a director, Chief Executive Officer and President of Escalade and all other executive
officer and director positions that he holds with Escalade and any of Escalade’s subsidiaries and their affiliates as of
the Employment End Date; and

 

D. Executive
and the Company are parties to that certain Executive Severance Agreement dated as of June 9, 2016, as amended as of June 25, 2019
(the “Executive Agreement”), which Executive Agreement represents the parties’ mutual agreement with respect
to all matters related to Executive’s termination of employment with the Company, except to the extent expressly provided
otherwise herein. All capitalized terms used in this Agreement and not defined herein shall have the meaning set forth in the Executive
Agreement.

 

NOW, THEREFORE, in consideration of the
mutual promises contained in this Agreement, the Company and Executive agree as follows:

 

1. Termination.
Executive hereby affirms that his positions as Chief Executive Officer and President of Escalade and from all other executive officer
and director positions that he holds with Escalade and any of Escalade’s subsidiaries and their affiliates, will terminate
effective as of the Employment End Date. Executive acknowledges and agrees that as of the Employment End Date he also will retire
as a trustee or other administrator of any and all Company benefit plans, including without limitation the Company’s retirement
plan. Executive and the Company agree that Executive’s intended resignation as a Director of Escalade is not related to any
disagreement between them that would require disclosure pursuant to Item 5.02(a) of Form 8-K or any successor provision thereto.
Executive further acknowledges and agrees that he will continue as Escalade’s President and Chief Executive Officer and will
provide ongoing services through the Employment End Date, such services to be consistent with services provided by Executive prior
to the Effective Date.

 

    1 

     

    

 

2. Compensation
and Benefits. Provided that Executive fulfills his obligations as set forth in this Agreement, the Company shall pay to Executive
the following Severance Benefits:

 

(a) the
Company shall continue to pay the Executive his Base Salary and continue his Employee Benefits through the Employment End Date;

 

(b) at
the end of the Company’s 2019 fiscal year, the Company will determine if Incentives have been met and the incentive compensation
amount payable, as if the Executive had served the full year in the event the Employment End Date would precede the end of the
2019 fiscal year, and will pay the Executive the proportionate amount of such incentive compensation on the same date the Company
first makes incentive payments to other employees receiving similar Incentives;

 

(c) the
Company will pay Executive additional payments equal in the aggregate to one year Base Salary for the period commencing on the
day following the Employment End Date and ending on the second anniversary of the Employment End Date, payable on a pro rata basis
in accordance with the regular payroll practices of the Company as applicable to the Executive immediately prior to the Employment
End Date;

 

(d) all
equity incentive awards granted to the Executive and outstanding as of the Employment End Date shall be treated in the manner set
forth in the applicable Incentive Compensation Plan of the Company, provided, however, that, (i) to the extent not already vested,
all stock options held by Executive shall be fully vested as of the Employment End Date and shall remain exercisable through the
expiration date stated in the applicable award document, and (ii) all restricted stock units held by Executive shall continue to
vest and be paid following the Employment End Date based on Executive’s ongoing service as a consultant to the Company pursuant
to Section 3(h) hereof rather than based on employment, and that all other vesting conditions relating to such restricted stock
units shall be deemed satisfied as of the Employment End Date; and further understood and agreed that all equity incentive awards
that are not exercised or that do not vest prior to the expiration date of such award as stated in the applicable award document
shall be forfeited and of no further effect after such expiration date; and

 

(e) with
respect to the Executive and his family members who are covered by the Company’s medical plan as of the Effective Date, subject
to meeting ongoing eligibility requirements, the Executive and those family members shall be entitled to continue to participate
in the Company’s medical plan in the same manner as currently participating, such that Executive will pay the employee portion
of the applicable premiums and the Company will pay the remaining portion, provided, however, that if the Executive would no longer
be eligible to participate directly in the Company’s medical plan, then Executive and those family members shall be entitled
to the continuation of such health care benefits under the provisions of the Consolidated Omnibus Budget Reconciliation Act or
any substantially equivalent successor law (“COBRA”), and the Company will pay the applicable COBRA premiums
on his behalf for the 12 months following the date on which Executive ceases to be a direct participant in the Company’s
medical plan, but in no event later than March 9, 2022 (and the Executive shall be responsible for all COBRA premiums after the
expiration of the foregoing period).

 

    2 

     

    

 

In the event of Executive’s death prior to the Employment
End Date, then Executive’s estate shall receive all of the above benefits.

 

3. Executive’s
Obligations. In consideration of the payments and benefits provided in Section 2 above, Executive will:

 

(a) fully
cooperate and assist the Company with any litigation matters or regulatory or agency proceedings for which his testimony or cooperation
is requested by Company following the Employment End Date, provided that he is reimbursed for any reasonable and necessary expenses
incurred as a result of his cooperation and assistance, and further provided that the Company and Executive shall discuss in advance
of Executive’s providing any such cooperation and assistance the anticipated time commitment that would likely be required
of Executive with respect to any such matter and shall mutually determine whether Executive should be compensated for his time
and the amount of any such compensation, it being understood and agreed that if the parties cannot reach agreement as to any such
compensation, then the Company shall not request, and Executive shall not be required, to provide cooperation and assistance with
respect to such litigation or proceeding;

 

(b) sign
all necessary resignations from the boards of directors and/or all other officer, employee and trustee positions of the Company,
but in any event Executive shall be deemed to have resigned any such executive officer, director and trustee positions as of the
Employment End Date;

 

(c) through
the Employment End Date, except as provided in clause (d) below, continue to comply with the Company’s Insider Trading Policy,
Code of Ethics and all other Company policies and procedures applicable to employees of the Company including, without limitation,
no destruction of any documents belonging to or relating to the Company or Executive’s employment with the Company, whether
in paper, electronic, digital or any other format, unless such destruction is approved in advance and observed by an officer of
the Company specifically designated and authorized by Escalade’s Board of Directors;

 

(d) comply
with the Company’s Policy for Recovery of Incentive Compensation through the end of the look back period, which look back
period shall be deemed to commence on the Employment End Date and continue for three years thereafter;

 

(e) comply
with all laws relating to the Company’s business and operations as applicable to Executive and the Company;

 

(f) comply
with all covenants contained in the Executive Agreement and in this Agreement, including without limitation Sections 4, 5 and 6
hereof;

 

(g) between
the Effective Date and the Employment End Date, perform Executive’s duties as Escalade’s President and Chief Executive
Office in a professional manner and on a full time basis, which duties shall include Executive’s reasonable best efforts
to facilitate a smooth transition of responsibilities to his successor; and

 

(h) after
the Employment End Date and through the later of the second anniversary thereof or March 9, 2022, Executive shall serve as a consultant
to the Company, providing consulting services as shall be reasonably requested by the Company upon reasonable advance notice, it
being understood and agreed that the amount of consulting services provided by Executive shall be no more than twenty percent (20%)
of the average amount of services provided by Executive during the thirty six month period prior to the Employment End Date.

 

4. Mutual
Nondisparagement.

 

(a) Executive’s
Covenant. Beginning on the Effective Date, Executive shall not make, participate in the making of, or encourage any other person
to make, any statements, written or oral, which criticize, disparage, or defame the reputation of, or which embarrass the Company,
its subsidiaries and their affiliates or any of their respective present, former or future directors, officers, executives, employees
and/or shareholders.

 

(b) Company’s
Covenant. Beginning on the Effective Date, the Company shall not, and shall instruct the members of Escalade’s Board
of Directors and executive officers not to, make, participate in the making of, or encourage any employees or any other person
to make, any statements, written or oral, which criticize, disparage, or defame the reputation of, or which are intended to embarrass,
the Executive.

 

5. Confidentiality.
Executive understands and agrees that:

 

(a) Escalade is required to describe the material terms of this Agreement in a Current Report on Form 8-K to be filed with the Securities
and Exchange Commission no later than four (4) business days after this Agreement is signed by the Executive and Escalade, and
that the Company will attach this Agreement in its entirety as an Exhibit to such public filing;

 

    3 

     

    

 

(b) through
the Employment End Date, in the course of his employment with the Company and service as a director of Escalade, Executive has
been and will be entrusted with, or has obtained or will obtain, access to information proprietary to the Company with respect
to the following (all of which information is referred to hereinafter collectively as the "Information"): the
organization and management of the Company; the names, addresses, buying habits, and other special information regarding past,
present and potential customers, employees and suppliers of the Company; customer and supplier contracts and transactions or price
lists of the Company and their suppliers; products, services, programs and processes sold, licensed or developed by the Company;
technical data, plans and specifications, present and/or future development projects of the Company; financial and/or marketing
data respecting the conduct of the present or future phases of business of the Company; computer programs, systems and/or software;
ideas, inventions, trademarks, trade secrets, business information, know-how, processes, improvements, designs, redesigns, discoveries
and developments of the Company; and other information considered confidential by any of the Company or its customers or suppliers.
At all times through the Employment End Date and thereafter, Executive agrees to retain the Information in absolute confidence
and not to disclose the Information to any person or organization except as required in the performance of Executive's duties for
the Company as provided in this Agreement, without the express written consent of the Company; provided that Executive’s
obligation of confidentiality shall not extend to any Information which becomes generally available to the public other than as
a result of disclosure by Executive, and further provided that, pursuant to the Defend Trade Secrets Act of 2016, Executive shall
not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that
is made in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney, and
solely for the purpose of reporting or investigating a suspected violation of law, or for the disclosure of a trade secret that
is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal;

 

(c) Executive
and the Company agree that effective upon the Company’s filing of its Form 10-K for the fiscal year in which the Employment
End Date occurs, but in no event earlier than the filing of its Form 10-K for the Company’s 2020 fiscal year, Executive will
no longer be privy to material, non-public information regarding the Company. Accordingly, the Company agrees that Executive shall
not be subject to the Company’s Insider Trading Policy thereafter, provided, however, that if and to the extent that Executive
may from time to time acquire knowledge of material, non-public information regarding the Company (whether in his capacity as a
consultant to the Company or otherwise), Executive acknowledges and agrees that he may not trade based upon such information and
must comply with all applicable laws prohibiting insider trading. The Company further agrees that it will not intentionally provide
material, non-public information to Executive following the Employment End Date except in connection with such events, actions
or circumstances that would require stockholder approval and the Company has made a good faith determination that it is necessary
and appropriate to disclose such information to Executive given his then current ownership of Escalade common stock, and that the
Company will use its reasonable best efforts to prevent any inadvertent disclosures of material, non-public information to Executive;

 

(d) Notwithstanding
the foregoing, in the event that the Executive is requested or required by law, regulatory authority or other applicable judicial
or governmental order to disclose any Information, the Executive will provide the Company with prompt notice of any such request
or requirement (if legally permissible) so that the Company may seek a protective order or other appropriate remedy and/or waive
compliance with the terms of this Agreement with respect to non-disclosure of such Information. In the event that such protective
order or other remedy is not obtained, or that the Company waives compliance with the terms hereof as set forth above, the Executive
may disclose only that portion of the Information which is legally required; and

 

(e) On
or promptly following the Employment End Date, Executive will return all Company issued electronic devices (including without limitation,
laptops, smart phone, tablets, and similar devices) and Company information to the Company, will no longer access any Escalade
data processing or information systems, and will allow the Company to inspect any and all electronic devices, whether owned by
the Company or Executive, to delete any and all Company data and access to Company systems from such devices. Upon deletion of
all Company data and removal of access to Company systems from the Executive’s smart phone and laptop, the Executive shall
be entitled to keep such phone and laptop for his personal use, if he so desires, at no cost to the Executive.

 

6. Covenant
Not to Compete, No Interference; No Solicitation. At all times through the twelfth month following the Employment End Date
(or if this period is unenforceable by law, then for such shorter period as shall be enforceable):

 

(a) Executive
will not engage in any business offering products or services related to the current business of the Company, whether as a principal,
partner, joint venture, agent, employee, salesman, consultant, director or officer, where such business or business activity is
in competition with the Company in any geographic market where the Company does business; provided, however, that Executive shall
not be prohibited from performing services for a subsidiary or division of a competitive business, as long as (i) such subsidiary
or division is not in competition with the Company, (ii) the revenues of the competitive business relating to its products and
services that are in competition with the Company constitute five percent (5%) or less of its total revenues, and (iii) the Executive
abides by all other provisions of this Agreement including without limitation Sections 4, 5, 6(b) and 6(c);

 

(b)Executive will not interfere with or adversely affect,
either directly or indirectly, the Company’s relationships with any person, firm, association, corporation or other entity
which is known by Executive to be, or is included on any listing to which Executive had access during the course of his employment
as a customer, client, supplier, consultant or employee of the Company, and Executive will not divert or change, or attempt to
divert or change, any such relationship to the detriment of the Company or to the benefit of any other person, firm, association,
corporation or other entity; and 

 

(c) Executive
will not induce, seek to induce or participate directly or indirectly with any third party in seeking to induce, any other employee
of the Company to terminate his or her employment relationship with the Company, provided, however, that this restriction shall
not prohibit Executive from hiring any employee who seeks employment from Executive or any third party with whom Executive may
be employed or affiliated with in the future on an unsolicited basis as long as such employment is not in competition with any
business or operations of the Company.

 

    4 

     

    

 

Executive acknowledges and agrees that the
covenants, restrictions, agreements, and obligations set forth herein are founded upon valuable consideration, and, with respect
to the covenants, restrictions, agreements, and obligations set forth in this Section 6 are reasonable in duration and geographic
scope. The time period and geographical area set forth in this Section 6 are each divisible and separable, and, in the event that
the covenants not to compete and/or not to divert business or employees contained therein are judicially held invalid or unenforceable
as to such time period and/or geographical area, they will be valid and enforceable in such geographical area(s) and for such time
period(s) which the court determines to be reasonable and enforceable. Executive agrees that in the event that any court of competent
jurisdiction determines that the above covenants are invalid or unenforceable to join with the Company in requesting such court
to construe the applicable provision by limiting or reducing it so as to be enforceable to the extent compatible with the then
applicable law. Furthermore, it is agreed that any period of restriction or covenant hereinabove stated shall not include any period
of violation or period of time required for litigation or arbitration to enforce such restrictions or covenants.

 

7. Tax
Liability; Tax Withholding. Executive acknowledges and agrees that he is responsible for the payment of all taxes relating
to the consideration to be provided to him as contemplated by this Agreement, including the payment of any taxes relating to his
exercise of stock options and his receipt of any stock, cash or other consideration relating to any other equity incentive awards
he may have received from the Company. Notwithstanding any other provision of this Agreement, the Company will withhold from any
amounts payable under this Agreement, or any other benefits received pursuant hereto, such federal, state and/or local taxes as
shall be required to be withheld under any applicable law or regulation.

 

8. No
Mitigation; No Offset. In no event shall Executive be obligated to seek other employment or to take any other action that would
mitigate the amounts payable to Executive under this Agreement. In the event that Executive would obtain subsequent employment,
the Company may not offset any compensation or other amounts earned by Executive from such subsequent employment or engagement
of his services against the Executive’s entitlements under this Agreement. Moreover, subject to Executive’s compliance
with the covenants set forth in Sections 4, 5 and 6 of this Agreement, Executive shall be free to pursue any unsolicited, non-competitive
opportunities for employment or services as may arise from the Company’s customers, vendors, employees and affiliates.

 

9. Section
16 Reports. Executive and the Company agree that notwithstanding Executive’s termination as an executive officer and
a director of Escalade as of the Effective Date, Executive may continue to be subject to the reporting requirements of Section
16 of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder for up to six months following
the Employment End Date. Accordingly, Executive agrees to provide timely notice to Escalade’s chief financial officer of
all transactions undertaken by Executive in Escalade common stock, including the purchase or sale of any shares of Escalade common
stock and the exercise of any stock options, during the six month period following the Employment End Date, and the Company shall
prepare and file the appropriate Section 16 reports with the Securities and Exchange Commission on behalf of Executive. Upon the
conclusion of such six month period, the Company acknowledges that Executive will no longer be deemed an affiliate of the Company
and, absent Executive being in possession of material, non-public information concerning the Company, may freely engage in trades
of Escalade securities.

 

10. Remedies.

 

(a) Arbitration;
Submission to Jurisdiction. Any dispute that may arise between the Company and Executive relating to this Agreement and the
subject matter hereof shall be settled by binding arbitration in accordance with Section 9 of the Executive Agreement.

 

(b) Injunctive
Relief. Executive agrees that in the event of any actual or threatened breach by him of any of the provisions contained in
this Agreement, including those covenants specifically set forth in Sections 3, 4, 5 and 6 hereof, the Company shall be entitled
to seek immediate temporary injunctive and other equitable relief, without the necessity of showing actual monetary damages, subject
to hearing as soon thereafter as possible. In the event of such injunctive relief, the periods of time referred to in Sections
5 and 6 shall be deemed extended for a period equal to the respective period during which Employee is in breach thereof, in order
to provide for injunctive relief and specific performance for a period equal to the full term thereof and the Company shall be
entitled to cease its obligations to Executive pursuant to Section 2. In the event that the Company breaches its obligations to
make payments and to provide the benefits specified in Section 2 hereof, Executive may seek specific performance in addition to
monetary damages and Executive will not be subject to the provisions of Section 4, 5 or 6 hereof. Nothing contained herein shall
be construed as prohibiting Executive or the Company from pursuing any other remedies available to it for such breach or threatened
breach, including the recovery of any damages which it is able to prove.

 

11. Mutual
Release. In consideration of the payments and benefits set forth in this Agreement, such payments and benefits being good and
valuable consideration:

 

(a) Release
by Executive. Subject to Section 10(b), Executive, on his own behalf and on behalf of his heirs, administrators, executors,
successors, assigns and personal representatives, covenants not to sue and hereby fully and forever releases, acquits and discharges
the Company, its shareholders, directors, officers, employees, agents, representatives, insurance carriers, and their successors
and assigns (collectively the “Releasees”), from any and all claims, demands, actions and causes of action of every
kind, nature or description (collectively “claims”) that Executive may have had, may now have, or may hereafter have
against Releasees, including without limitation any and all claims in any way related to or based upon Executive’s service
as an executive officer and director of the Company through the Effective Date and/or the cessation of Executive’s service
as an employee, executive officer and director of the Company, including without limitation any claims for breach of contract,
implied contract, promissory estoppel, tortious conduct or claims arising under any federal or state statute or law or local ordinance,
including but not limited to: the Age Discrimination in Employment Act as amended (“ADEA”); Older Workers’ Benefit
Protection Act (“OWBPA”); Americans with Disabilities Act (“ADA”) as amended; the Family and Medical Leave
Act (“FMLA”); Title VII of the Civil Rights Act of 1964; the Civil Rights Acts of 1991; the Employee Retirement Income
Security Act (“ERISA”); 42 U.S.C. § 1981; 29 U.S.C. § 206(d)(1); Section 503 and 504 of the Rehabilitation
Disabilities Act; the WARN Act; Indiana’s fair employment practices statutes; any other federal, state or local law dealing
with employment discrimination; and any federal or state “Whistleblower” law, existing as of the date of this Agreement.
Provided, however, that if the Company were to breach this Agreement, this release would not bar an action by Executive against
the Company to enforce its term(s) or any applicable law. In addition, this Section 11(a) shall not affect adversely any benefits
to which Executive may be entitled arising out of any social security, workers' compensation or unemployment laws, or under the
terms of any employee pension or welfare or benefit plans or programs of the Company, which may be payable now or in the future
to Executive.

 

    5 

     

    

 

(b) Acknowledgements
by Executive. Executive specifically acknowledges and agrees that: (i) Executive is waiving claims under the foregoing laws,
including specifically the ADEA and the OWBPA; (ii) this waiver of any rights or claims is knowing and voluntary; (iii) this Agreement
is written in a manner that Executive understands; (iv) the Company has hereby advised Executive to consult with an attorney before
executing this Agreement and that Executive has so consulted; (v) the waiver of rights under Section 11(a) does not waive rights
or claims arising after the date of this Agreement; (vi) Executive has been given a period of 21 days within which to consider
this Agreement; (vii) for a period of seven days following Executive’s execution of this Agreement, Executive may revoke
this Agreement and this Agreement will not become enforceable or effective until the revocation period expires; and (viii) the
waiver of rights in Section 11(a) is in exchange for consideration in addition to anything of value to which Executive was already
entitled to receive.

 

(c) Release
by the Company. Subject to Section 10(b), the Company, on behalf of itself and its successors and assigns, covenants not to
sue and hereby fully and forever releases, acquits and discharges Executive and his successors and assigns, from any and all claims,
demands, actions and causes of action of every kind, nature or description (collectively “claims”) that the Company
may have had, may now have, or may hereafter have against Executive, including without limitation any and all claims in any way
related to or based upon Executive’s employment with the Company, its subsidiaries and affiliates through the Effective Date
and/or the cessation of Executive’s service as an executive officer or director of the Company, including without limitation
any claims for breach of contract, implied contract, promissory estoppel, tortious conduct or claims arising under any federal
or state statute or law or local ordinance, existing as of the date of this Agreement. Provided, however, that if Executive were
to breach this Agreement, this release would not bar an action by the Company against Executive to enforce its term(s) or any applicable
laws. In addition, this Section 11(c) shall not bar any action by the Company against Executive to enforce the terms of the Company’s
Policy for Recovery of Incentive Compensation and/or Section 5(b) of the Executive Agreement.

 

(d) Unknown
Claims. This Agreement covers both claims that Executive and/or the Company know about and those that Executive and/or the
Company may not know about. The parties hereto expressly waive all rights afforded by any statute that limits the effect of a release
with respect to unknown claims, except as to any claims that Executive may have as contemplated by the last two sentences of Section
11(a) or that Company may have as contemplated by the last two sentences of Section 11(c). Each of Executive and the Company understand
the significance of its respective release of unknown claims and the waiver of statutory protection against a release of unknown
claims. However, this release shall not apply to any claim based on the fraud or intentional misconduct of the other party or to
any act that is determined to be a criminal act under any federal, state or local law committed or perpetrated by Executive or
the Company at any time prior to and through the Employment End Date. Neither Executive nor the Company, based on the knowledge
of Escalade’s Board of Directors and of the Company’s executive officers other than Executive, is currently aware of
any fraud or intentional misconduct of the other party to this Agreement.

 

(e) Future
Claims Related to Employee and/or Shareholder Status. Notwithstanding any provision of this Section 11 that may be construed
to the contrary, Executive and the Company agree that neither Executive nor the Company waive or release the other party hereto
from any claim that may arise based on events occurring after the Effective Date. Executive and the Company further agree that
Executive may not, based upon Executive’s status as a shareholder of the Company, assert any claim subsequent to the Effective
Date against the Company or any Releasees relating to any potential claim or matter that is the subject of or is otherwise covered
by the release granted by Executive in this Agreement or is in any way related to the event of Executive’s retirement from
or cessation of employment with the Company.

  

(f) Additional
Release. Provided that Executive has signed and delivered on or promptly after the Employment End Date to the Company a general
release substantially identical in form and substance to the release set forth in this Section 11 (the “Additional Release”)
relating to claims arising or that may arise from events on or after the Effective Date through the Employment End Date (the “Continuing
Employment Period”), which Additional Release by its terms has become effective and is in material compliance with the
terms of this Agreement, the Company further releases Executive, his successors and assigns from any and all claims, demands, actions
and causes of action of every kind, nature or description (collectively “claims”) that the Company may have had, may
now have, or may hereafter have against Executive, including without limitation any and all claims in any way related to or based
upon Executive’s employment with the Company during the Continuing Employment Period and/or the cessation of Executive’s
service as an employee of the Company, including without limitation any claims for breach of contract, implied contract, promissory
estoppel, tortious conduct or claims arising under any federal or state statute or law or local ordinance, existing as of the date
of this Agreement and the Company shall sign and deliver at such time a general release to such effect identical in form and substance
to the release contained herein. Provided, however, that if either party were to breach this Agreement, such further release would
not bar an action by the non-breaching party against the breaching party to enforce its term(s) or any applicable laws nor would
such release cover any action based on a claim excluded from the release by Section 11(d).

 

12. Future
Service as Employee, Executive Officer or Director. Executive agrees that his termination as an employee, executive officer
and director of the Company is irrevocable, and that the Company shall have no obligation whatsoever to rehire, reappoint or elect
Executive to any such officer, director or other position with the Company. Executive further agrees that if he would seek any
such position and is not so hired, nominated, appointed or elected, Executive will not bring a claim against the Company and/or
any Releasee for refusal to so hire, nominate, appoint or elect.

 

13. Binding
Effect; Authority. This Agreement shall bind the Executive’s heirs, executors, administrators, personal representatives,
spouse, dependents, successors and assigns. Escalade represents and warrants to Executive that the individual signing this Agreement
on behalf of the Company is duly authorized to enter into this Agreement and to bind the Company hereunder.

 

14. Non-Admission.
This Agreement shall not be construed as an admission by either party of any wrongdoing or any violation of any federal, state
or local law, regulation or ordinance, and the parties specifically disclaim any wrongdoing or violation.

 

    6 

     

    

 

15. Assignability.
Neither this Agreement, nor any right or interest hereunder, shall be assignable by Executive, his beneficiaries or legal representatives,
without the prior written consent of an executive officer of Escalade.

 

16. Entire
Agreement. This Agreement sets forth the entire agreement between the parties with respect to the subject matter hereof and
supersedes any other written or oral promises concerning the subject matter of this Agreement except as expressly stated otherwise
herein or except as expressly stated otherwise in the Executive Agreement. The terms of this Agreement may not be modified other
than in a writing signed by the parties.

 

17. Governing
Law. This Agreement shall in all respects be interpreted, enforced and governed by the laws of the State of Indiana without
giving effect to provisions thereof regarding conflict of laws.

 

18. Counterparts. This Agreement
may be executed in one or more counterparts, each of which shall constitute an original and all of which shall together constitute
one and the same instrument.

 

In Witness Whereof, the parties have entered
into this Agreement and Release as of this 21st day of November, 2019. 

 

 

	 	By: /s/ DAVID L. FETHERMAN 

David
L. Fetherman

 

 

ESCALADE,
INCORPORATED

 

 

By:
/s/ WALTER P. GLAZER, Jr.

Walter
P. Glazer, Jr.

Chairman

	 	 
	 	 

  

    7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}]]